X 
Directors Report
Home | Market Info | Company Profile | Directors Report
Tatva Chintan Pharma Chem Ltd.
BSE CODE: 543321   |   NSE CODE: TATVA   |   ISIN CODE : INE0GK401011   |   03-May-2024 Hrs IST
BSE NSE
Rs. 1245.55
18.55 ( 1.51% )
 
Prev Close ( Rs.)
1227.00
Open ( Rs.)
1231.55
 
High ( Rs.)
1255.90
Low ( Rs.)
1226.75
 
Volume
839
Week Avg.Volume
1417
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1243.70
15.55 ( 1.27% )
 
Prev Close ( Rs.)
1228.15
Open ( Rs.)
1239.95
 
High ( Rs.)
1255.00
Low ( Rs.)
1225.00
 
Volume
11338
Week Avg.Volume
10950
 
52 WK High-Low Range(Rs.)
1061.35
1887.95
March 2019

Disclosure in board of directors report explanatory

 

 

DIRECTORS REPORT

 

 

To,

The Members,

The board is pleased to present 23rd Annual Report on the business and operations of the Company together with The Audited Financial Statements (Standalone and Consolidated) for the financial year ended 31st March 2019.

 

1.        COMPANY OVERVIEW:

 

Your company is a vertically integrated Chemical company having presence in multiple speciality, Company is manufacturing whole range of Phase Transfer Catalyst (PTC) includes Quaternary Ammonium Compounds and Quaternary phosphonium Compounds. Company is having manufacturing facilities at Ankleshwar and Dahej and R&D center at Vadodara. Products are having wide range of application e.g. pharmaceutical intermediate, agro industries, surface active agent, cosmetics etc.

 

2.        FINANCIAL RESULTS:

A summary of the Company's financial results for the Financial Year 2018-19 is as under:

 ( ? in Lacs)

Particulars

Standalone

Consolidated

2018-19

2017-18

2018-19

2017-18

Net Revenue /Income

20006.54

13421.35

20628.44

14024.27

Gross profit before interest and depreciation

3283.21

2514.60

2992.40

2627.41

Finance Cost

485.04

315.75

485.04

315.75

Profit before depreciation and amortization -

(Cash Profit)

2798.17

2198.85

2507.36

2311.66

Depreciation and amortization

503.17

358.36

503.17

358.36

PBT before exceptional items

2295.00

1840.49

2004.19

1953.30

Exceptional items

-72.12

2.23

-72.12

2.23

Profit before Tax (PBT)

2367.12

1838.26

2076.31

1951.06

Provision for Tax : Current

453.24

529.40

514.18

533.41

Provision for Tax : Deferred

111.16

117.69

111.16

117.69

Profit after Tax

1802.72

1191.17

1450.97

1299.96

 

 

Exchange Rate as on 31/03/2018 1 USD = 65.0441 INR

Exchange Rate as on 31/03/2019 1 USD = 69.1713 INR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.        DIVIDEND:

The Board of Directors of your Company after considering holistically the relevant circumstances has decided that it would be prudent, not to recommend any divided for the year under review.

 

4.        TRANSFER TO RESERVES:

The Board has decided to retain the entire amount of profits in the profit and loss account for the year under review

 

5.        REVIEW OF BUSINESS ORERATIONS AND FUTURE PROSPECTS[A1] :

Your Directors wish to present the details of Business Operations done during the year under review as under Pprofit before tax increased by 28.77% from Rs.1,838.26  lakhs in FY 2017-18 to Rs. 2,367.12 lakhs in FY 2018-19 due to efficient operations at Phase I and II at Dahej Unit-I..

 

Export Sales increased by 66.00% from Rs. 8399.31 lakhs during FY 2017-18 to Rs. 13943.10 lakhs during FY 2018-19. Domestic Sales increased by 29.69% over previous year from Rs. 4543.81 Lakhs to Rs. 5,892.98 Lakhs during the year under review.

 

To reduce cost of Export Freight and Insurance and to expedite Export Deliveries, your company arranged warehouse facility in Netherlands and promoted wholly-owned subsidiary in USA under the name and style of TATVA CHINTAN USA, Inc. during FY 2016-17. Sales achieved from Netherlands warehouse amounted to Rs. 726.36 Lakhs during FY 2018-19 and by USA subsidiary amounted to Rs. 4470.02 Lakhs during FY 2018.

 

The Export share in "Revenue from Operations" is 71.03% during FY 2018-19. The business continued to experience headwinds in demand generation from both global and domestic majors. The efforts on creating a diversified portfolio of innovative products, winning new customers and penetration into new markets is ongoing. The key emphasis of this business has been on investing in research and development, towards building a strong product portfolio in Quaternary, Hydroxides and Specialty chemicals.

 

In order to widen market in Europe, wholly owned subsidiary has been established in the name and style of Tatva Chintan Europe B.V. in March, 2019.

 

During the year the costs of key raw materials moved in mixed directions. The Company continued its strategy of importing raw materials from diverse sources and achieve in maintaining a steady price during the year. Some raw materials experienced strong inflationary trends exerting stress on the margins across product lines.

 

FY 2018-19 saw volatility in USD-INR, ranging from Rs. 64.90 and Rs. 74.10, and averaging at 70.07. There was also significant volatility in exchange rates of emerging markets' currencies. Towards the end of the current fiscal it was around Rs. 69.1713. The exchange loss of Rs. 177 Lakhs is reported in Profit and Loss account during the year, which is on account of timing difference of foreign exchange revenue transactions and their realization and/or re-statement. Also, we have capitalized exchange loss of Rs. 39 Lakhs.

 

Phase III of Unit I at Dahej SEZ. is currently under process and is expected to be completed in last quarter of FY 2019-20.The new capacity is expected to come on stream by last quarter of FY 2019-20. The expanded capacity will be utilized for the Company's growing export market. The investment in expansion of the capacity is based on customer inquiries and discussions and in anticipation of future research pipelines. The new capacity addition will be similar to the Company's existing multi-product plant configuration with multistage batch and products processing capabilities. The Company has reached out to markets in the US, Europe and Japan by having direct representations in those geographies, in addition to the strong presence of Tatva Chintan (USA) Inc. in USA.

 

 

 

 

Through the year, the technology teams worked relentlessly to improve productivity, quality and costs of various products to offer a competitive marketing edge to the businesses on one hand and flexibility of sourcing to the supply chain team on the other. Continuous focus on improving operating efficiencies across manufacturing and supply chain applications, during the year, have helped the Company improve its margins and secure deeper penetration in the market. The top-line growth coupled with higher capacity utilization, helped in better absorption of overheads, contributing to improvements in the operating margins. Slack in high-margin products during second half resulted into reduction in overall operating margins for the fiscal.

 

During the year a conservative inventory policy was followed in order to remain closer to the market prices of all the raw materials and access the resultant movement in the finished product prices.

 

The receivables and inventories management have been an area of key management attention and are in line with the scope and scale of operations and the levels were well within acceptable industry norms.

 

The Company is fully committed to its responsibilities in health, safety and environment (HSE) management and has continued to make sizeable investments in HSE during the year.

 

6.        PERFORMANCE AND FINANCIAL POSITION OF EACH SUBSIDIARIES, ASSOCIATES AND JOINT VENTURE COMPANIES :

The Consolidated Financial Statements of the Company are prepared in accordance with relevant Accounting Standards issued by the Institute of Chartered Accountants of India and forms an integral part of this Report.

During the period under review, Tatva Chintan Europe B.V. was incorporated, which is yet to commence its business. A statement containing the salient features of financial statements of each of the subsidiaries, associates and joint venture companies in terms of provisions of Section 129(3) of the Companies Act, 2013 in the prescribed Form AOC- 1 is annexed ( Annexure -I) to this report and hence not repeated here for the sake of brevity.

 CHANGE IN NATURE OF BUSINESS, IF ANY:

There is no change in the nature of business of the Company during the financial year under review.

7.        MATERIAL CHANGES AND COMMITMENT IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR TO WHICH THIS FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT:

No material changes and commitments affecting the financial position of the Company occurred between the end of the financial year i.e. March 31, 2019 and the date of Directors' Report i.e. September 21,2019

 

8.        DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY'S OPERATIONS IN FUTURE:

No significant or material orders passed by the regulators or courts or tribunals impacting the going concern status and company's operations in future during the financial year and/or subsequent to the close of the financial year of the Company to which the balance sheet relates and the date of the report.

 

 

 

 

 

9.        EXTRACT OF ANNUAL RETURN:

Pursuant to sub-section (3) of Section 92 of theCompanies Act 2013, read with Rule 12 of the Companies(Management and Administration) Rules, 2014 the extractof the Annual Return as at March 31, 2019 forms part ofthis report as Annexure: IV.

 

As required under Section 134(3)(a)of the Act, the Annual Return (Form MGT-7) shall be put up on the Company's website and can be accessed at www.tatvachintan.com.

 

10.    CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO:

The information pertaining to conservation of energy, technology absorption, Foreign Exchange Earning and Outgo as required under Section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014 and amendment thereof is furnished in Annexure II  and is attached to this report.

 

11.    DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS APPLICABILTY OF INTERNAL AUDIT:

 

Internal Financial Controls are an integrated part of therisk management process, addressing financial risksand financial reporting risks. The Board has adoptedpolicies and procedures for ensuring the orderly andefficient conduct of its business, including adherence tothe Company's policies, the safeguarding of its assets,the prevention and detection of frauds and errors, theaccuracy and completeness of the accounting records,and the timely preparation of reliable financial disclosures.Assurance on the effectiveness of internal financialcontrols is obtained through management reviews,continuous monitoring by functional experts and testingof the internal financial control systems by the internalauditors during the course of their audits. We believethat these systems provide reasonable assurance thatour internal financial controls are designed effectivelyconsidering the nature of our industry and are operatingas intended.

 

From the financial statement 2018-19, it is informed that the turnover of the Company is ? 202,73,71,367/-. According to Section 138 of the Companies Act, 2013 and Rule 13 of Companies Accounts Rule, 2014 Board of Director of your company is required to appoint internal auditor. In the context of above provisions Board of Directors will appoint suitable internal auditor for your company.

 

12.    STATEMENT CONCERNING DEVELOPMENT AND IMPLEMENTATION OF RISK MANAGEMENT POLICY OF THE COMPANY:

Risk is an important element of corporate functioning and governance. Your Company has established the process and framed a policy of identifying, analyzing and treating risks, which could prevent the Company from effectively achieving its objectives. It ensures that all the risks are timely defined and mitigated in accordance with the well-structured risk management Process.

Global slowdown and recession is always a risk attached with the industry, and your company is taking necessary actions to protect the interest of the company against such market risks from time to time.

13.    DETAILS OF POLICY DEVELOPED AND IMPEMENTED BY THE COMPANY ON ITS CORPORATE SOCIAL RESPONSIBILITY INITIATIVES:

Your Company has formed the CSR Committee asper the requirement of the Companies Act, 2013. Onrecommendation of CSR Committee, the Board ofDirectors' of your Company has approved the CSR Policywhich is available on the website of your Company atwww.tatvachintan.com. The brief outline of theCorporate Social Responsibility (CSR) Policy of yourCompany and the initiatives undertaken on CSR activitiesduring the year are set out in Annexure III of this report inthe format prescribed in the Companies (Corporate SocialResponsibility Policy) Rules, 2014.

 

 

14.    PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186 OF THE COMPANIES ACT, 2013

Particulars of loans given and of the investments made by the Company as at March 31, 2019 are given in the Notes forming part of the Financial Statements. (Refer Note No.18 of Standalone financial Statement)

15.    PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES:

 

All related party transactions that were entered into during the year under review were on an arm's length basis and in the ordinary course of business.Further there are no material related party transaction during the year under review. Thus disclosure in Form AOC-2 in terms of Section 134 of the Companies Act, 2013 is not required. Attention of Members is drawnto the disclosure of transactions with related parties setout in Note No. 28 of Standalone Financial Statements, forming part of the Annual Report

 

16.    EXPLANATION OR COMMENTS ON QUALIFICATIONS, RESERVATIONS OR ADVERSE REMARKS OR DISCLAIMERS MADE BY THE AUDITORS AND THE PRACTICING COMPANY SECRETARY IN HIS SECRETSRIAL AUDIT REPORT:

There was no qualifications, reservations or adverse remarks or disclaimers made by the Auditors in their report on the Financial Statements of the Companyfor the financial year ended on March 31, 2019.Further Section 204 of the Companies Act, 2013 regarding Secretarial Audit is not applicable to Company.

17.    COMPANY'S POLICY RELATING TO DIRECTORS APPOINTMENT, PAYMENT OF REMUNERATION AND DISCHARGE OF THEIR DUTIES:

The provisions of Section 178(1) relating to constitution of Nomination and Remuneration Committee are not applicable to the Company.

18.    MANAGERIAL REMUNERATION:

The Company being private limited company, provisions of Section 197(12) of the Companies Act, 2013 read with Rule 5(1), 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are not applicable.

19.    NUMBER OF BOARD MEETINGS CONDUCTED DURING THE YEAR UNDER REVIEW:

During the year from April 1, 2018 to March 31, 2019 the Board of Directors met Eleven times on the following dates:

Sr.

No.

Date of meeting

Chintan N. Shah

Ajay M. Patel

Shekhar R. Somani

1

12/04/2018

Attended

Attended

Attended

2

08/05/2018

Attended

Attended

Attended

3

08/06/2018

Attended

Attended

Attended

4

03/07/2018

Attended

Attended

Attended

5

  16/08/2018

Attended

Attended

Attended

6

05/09/2018

Attended

Attended

Attended

7

06/09/2018

Attended

Attended

Attended

8

15/10/2018

Attended

Attended

Attended

9

21/11/2018

Attended

Attended

Attended

10

19/12/2018

Attended

Attended

Attended

11

25/02/2019

Attended

Attended

Attended

 

CSR COMMITTEE MEETINGS

Sr.

No.

Date of meeting

Chintan N. Shah

Ajay M. Patel

Shekhar R. Somani

1

26/08/2018

Attended

Attended

Attended

2

21/02/2019

Attended

Attended

Attended

 

20.    DIRECTORS RESPONSIBILITY STATEMENT:

In accordance with the provisions of Section 134(5) of the Companies Act, 2013 the Board hereby submit its responsibility statement -

(a)    In the preparation of the annual accounts for the year ended March 31,2019, the applicable accounting standards had been followed along with proper explanation relating to material departures;

(b)   The directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit and loss of the Company for that period;

(c)    The directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities.

(d)   The directors had prepared the annual accounts on a going concern basis

(e)    As company is not  listed This clause is not applicable

(f)    The directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

21.    DEPOSITS:

Your Company has not accepted any fixed deposits from the public as per the provisions of Section 73 to 76 of the Companies Act, 2013. Hence, the disclosures required as per Rule 8 (5) (v) & (vi) of the Companies (Accounts) Rules, 2014, are not applicable to your Company.

22.    DIRECTORS / KMP AND OTHER AUDIT DETAILS:

�  Directors:

 

There was no change (Appointment /Resignation) in directors during the year under review.

 

�  Change in Chief Financial Officer :

 

 Board of Directors of your Company has appointed Mr. Sudip Sanat Ray as Chief Financial Officer of the Company on 15/10/2018. And he ceased to be Chief Financial Officer of the Company w.e.f.close of working hours of 25/02/2019. Further Board of Directors of your company has appointed Mr. Vishnu Swarnakar as Chief Financial officer of the company with effect from 05/09/2019.

 

�  Change in  Company Secretary:

 

Ms. Hiral Gediya whole time Company Secretary ceased to be Company Secretary of Company w.e.f.close of working hours of 20/04/2019. The Board of Directors of your Company has appointed Ms. Mansi Ashar as whole time Company Secretary with effect from 22/07/2019.

 

 

�  DECLARATION OF INDEPENDENT DIRECTORS

The provisions of Section 149 pertaining to the appointment of Independent Directors do not apply to our Company.

 

�  STATUTORY AUDITORS

M/s.NDJ & Co.(Firm Registration No. 136345W), Chartered Accountants,Surat have been appointed as Statutory Auditors of the Company at the 22nd Annual General Meeting held on September 29, 2018 to hold office from the conclusion of 22nd Annual General Meeting (AGM) till the conclusion of the 27th Annual General Meeting of the Company, subject to compliance of the various provisions of Companies Act, 2013.The Auditors have confirmed that they are not disqualified from continuing asAuditors of the Company

�  SECRETARIAL AUDIT REPORT

 

The Secretarial Audit pursuant to Section 204(1) of the Companies Act, 2013 is not applicable to your Company.

 

�  COST AUDITORS

The maintenance of cost records has been specified by the Central Government under section 148(1) of the Companies Act, 2013 and the Company has maintained cost records pursuant to the Companies (Cost Records and Audit) Rules, 2014 as prescribed by the Central Government under sub-section (1) of Section 148 of the Companies Act, 2013

Pursuant to the provisions of Section 148 of the CompaniesAct, 2013 read with Rule 14 of the Companies (Auditand Auditors) Rules, 2014 the Board has appointed M/s. Y.S. Thakar & Co., Cost Accountants(Firm Registration No.:000318) as the Cost Auditors of the Company for FY 2019-20, The remuneration payable to the Cost Auditors is required to be placed before the Members in a General Meeting for their ratification. Accordingly, a resolution for seeking Members' ratification for the remuneration payable toM/s. Y.S. Thakar & Co., Cost Accountants(Firm Registration No.:000318)is included at Item No. 2 of the Notice convening the Annual General Meeting.

 

�  DISCLOSURE OF COMPOSITION OF AUDIT COMMITTEE AND PROVIDING VIGIL MECHANISM

 

The provisions of Section 177(1) of the Companies Act, 2013 read with Rule 6 of the Companies (Meetings of the Board and its Powers) Rules, 2013 regarding constitution of Audit Committee is not applicable to the Company.

Further provisions of Section 177 (9) of the Companies Act, 2013 read with Rule 7(b) of Companies (Meeting of Board and its Power) Rules, 2014 regarding establishment of Vigil Mechanism is applicable to Company. The Company promotes ethical behavior in all its business activities and has put in place a mechanism for reporting illegal or unethical behavior. The Company has a Vigil Mechanism and Whistle-blower policy under which the employees are free to report violations of applicable laws and regulations and the Code of Conduct. Board of directors has nominated Mr. Ajay Patel (DIN:00183745) to play the role of audit committee for the purpose of vigil mechanism to whom other directors and employees may report their concerns.

Details of establishment of Vigil Mechanism and Whistle-blower policy is put up on the Company's websitewww.tatvachintan.com.

 

 

 

 

 

 

 

�  INTERNAL CONTROLS

 

The internal control systems of the Company are effective and adequate for business processes with regards to efficiency of the operations, compliance with applicable laws and regulations, financial reporting, etc. which commensurate with the size and complexities of the operations.

 

All the Company's major business processes are currently run on SAP B1. The Company has established appropriate Internal Control framework in its operations and Financial Accounting and Reporting practices to ensure due adherence to the Internal Financial Control over Financial Reporting (IFCFR), under Section 143(3)(i) of the Companies Act, 2013.

 

The Company has established appropriate Internal Control framework in its operations and Financial Accounting and Reporting practices to ensure due adherence to the Internal Financial Control with reference to financial statements under Section 143(3)(i) of the Companies Act, 2013.

23.    CORPORATE GOVERNANCE REPORT

The Company, being private limited company, provisions of Corporate Governance Report is not applicable.

24.    SHARES

a)        BUY BACK OF SECURITIES

 

The Company has not bought back any of is securities during the year under review.

b)        SWEAT EQUITY

 

The Company has not issued any Sweat Equity Shares during the year under review.

c)        BONUS SHARES

 

No Bonus Shares were issued during the year under review.

 

d)        EMPLOYEES STOCK OPTION PLAN

The Company has not provided any Stock Option Scheme to the employees.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

25.    DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013

The SexualHarassment Policy provides for protection against sexualharassment of women at workplace and for preventionand redressal of such complaints. Your Company has complied with provisions relatingto the constitution of Internal Complaints Committeeunder the Sexual Harassment of Women at Workplace(Prevention, Prohibition and Redressal) Act, 2013. Therewere no complaints pending as on the beginning of thefinancial year and no new complaints were filed duringthe financial year under review.

 

 

26.    APPRECIATION:

Your Directors place on record their sincere thanks to bankers, business associates, consultants and various Government Authorities for their continued support extended to your Company's activities during the year under review.  Your Directors also acknowledges gratefully the shareholders for their support and confidence reposed on your Company.

 

 

FOR AND ON BEHALF OF BOARD OF DIRECTORS

                           TATVA CHINTAN PHARAM CHEM PRIVATE LIMITED

 

 

 

 

Date: September 21 , 2019

Place: Ankleshwar

  Mr. Ajay Patel

(Director)

(DIN: 00183745)

 

Mr. Shekhar Somani

(Director)

(DIN: 00183665)

 

 

                                               

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ANNEXURE -I

FORM NO. AOC-1

(Pursuant to first proviso to sub-section (3) of section129 read with rule 5 of Companies (Accounts) Rules, 2014)Statement containing salient features of the financial statement of subsidiary

Part- A Subsidiaries

(Information in respect of each subsidiary to be presented with amounts in ?.)

 

 

Sr. No.

 

Particulars/Amt ?

1

Sl. No.

 

1

2

Name of the subsidiary

 

TATVA CHINTAN USA, INC.
(Date of Incorporation 16/03/2015)

3

Reporting period for the subsidiary concerned, if different from the holding company's reporting period

01/01/2018 to 31/12/2018

4

 

Reporting currency and Exchange rate as on the last date of the relevant financial year in the case of foreign subsidiaries

Reporting currency:  US Dollar

Exchange Rate: 1$= ? 69.79

5

Share capital

66,91,150/-

6

Reserves and surplus

 

2,03,67,396.65

 

7

Total assets

 

18,21,44,623.55

 

8

Total Liabilities

 

18,21,44,623.55

 

9

Investments

 

NIL

10

Turnover

 

44,70,02,143.44/-

11

Profit before taxation

 

2,34,49,634.50/-

 

12

Provision for taxation

 

60,84,632.30/-

13

Profit after taxation

 

1,73,65,002.20

 

14

Proposed Dividend

 

NIL

15

Extent of shareholding (in percentage)

 

100%

 

 

 

 

 

 

Notes: The following information shall be furnished at the end of the statement:

 

1.         Names of subsidiaries which are yet to commence operations:

 

Tatva Chintan Europe BV (Date of Incorporation: 01-03-2019) 

 

 

2.         Names of subsidiaries which have been liquidated or sold during the year.:     None

                                                                                   

           

FOR AND ON BEHALF OF BOARD OF DIRECTORS

                           TATVA CHINTAN PHARAM CHEM PRIVATE LIMITED

 

 

 

 

For NDJ & Co.

Chartered Accountants

Firm Registration No: 136345W

 

 

 

 

(CA Shirish Shah)

Partner

M.  No.:035742

Date: 21-09-2019

Place: Surat

  Mr. Chintan Shah

(Director)

(DIN:00183618)

 

 

 

Mr. Ajay M. Patel

(Director)

(DIN: 00183745)

 

 

Mr. Shekhar Somani

(Director)

(DIN:00183665)

 

 

 

CA Vishnu Swarnkar

(Chief Financial Officer)

(MN: 127539)

 

Mansi Ashar

(Company Secretary)

(MN: A-58157)

Date: 21-09-2019

Place: Ankleshwar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                       

           

CONSERVATION OF ENERGY                                                  ANNEXURE II

 

(Pursuant to clause (m) of Section 134(3) read with Rule 8(3) of the Companies (Accounts) Rules, 2014)

 

Sr.

No.

Particulars

Details

(A)

CONSERVATION OF ENERGY -

 

(i)

The steps taken or impact on conservation of energy:

Conversion of CFL based lighting to LED lighting has been taken up during FY 2018-19 and completed

The replacement at continuous use area.

(ii)

The steps taken by the Company for utilising alternate sources of energy :

Company has not taken any steps to utilise renewal source of energy.

(iii)

Investment on energy conservation equipments

LED Lights - Rs. 5,95,725/-

 

(B)

TECHNOLOGY ABSORPTION -

 

(i)

The efforts made towards technology absorption:

The R&D team develops most of the processes for the new products through extensive literature survey, laboratory tests and pilot plant studies after which the products are manufactured on a semi-commercial scale and then on a commercial scale after successful completion of all the tests.

(ii)

The benefits derived like product improvement, cost reduction, product development or import substitution:

R&D activities reduced cost of production and development of new products which will increase turnover of the Company in future.

(iii)

In case of imported technology (imported during the last three years reckoned from the beginning of the financial year) -

Company has not imported any technology during last three financial years.

 

(a)    The details of technology imported:

Not Applicable.

 

(b)   The year of import:

Not Applicable.

 

(c)    Whether the technology been fully absorbed:

Not Applicable.

 

(d)   If not fully absorbed, areas where absorption has not taken place, and the reasons thereof; and

Not Applicable.

(iv)

The expenditure incurred on Research and Development.

Capital Expenditure -    Rs. 5,24,19,483.87

Revenue Expenditure - Rs. 1,43,83,647.02

Company established Research and Development Centre at 353, GIDC, Makarpura, Vadodara during current financial year. The same commenced operations on 02-04-2018.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

C. FOREIGN EXCHANGE EARNING AND OUTGO :

(Amt in ?)

Particulars

2018-19

2017-18

Total foreign exchange earned

1,12,73,30,590.82

87,41,91,729.51

Total foreign exchange used

57,00,58,707.50

26,80,42,900.69

 

:                                  

 

FOR AND ON BEHALF OF BOARD OF DIRECTORS

                           TATVA CHINTAN PHARAM CHEM PRIVATE LIMITED

 

 

 

 

Date: September 21, 2019

Place: Ankleshwar

  Mr. Ajay Patel

(Director)

(DIN: 00183745)

 

Mr. Shekhar Somani

(Director)

(DIN: 00183665)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ANNEXURE III

 

 

THE ANNUAL REPORT ON CORPORATE SOCIAL RESPONSIBILITY (CSR) ACTIVITIES

 

1.        A brief outline of the Company's CSR policy, including overview of projects or programs proposed to beundertaken and a reference to the web-link to the CSR policy and projects or programs:

 

Tatva Chintan Pharma Chem Private  Limited ('the Company') is committed to upholding the highest standards of CSR.  The Company believes in positively impacting the environment and supporting the communities it operates in, focusing on sustainability of our programs and empowerment of our communities. The contents of CSR policy can be accessed through the web link https://www.tatvachintan.com/csr-policy.html and details on projects and programmes undertaken are forming part of this Annual Report. Further Company is proposed to undertake activities in the area of  healthcare programmes, Education and other activities as per its CSR Policy.

 

2.        The Composition of the CSR Committee :

 Mr. Ajay M. Patel - Chairman

Mr. Chintan Shah - Member

Mr. Shekhar Somani- Member

 

3.        Average Net Profit of the Company for last three years -? 19,15,53,122.87/-

 

4.        Prescribed CSR Expenditure (two percent of the amount as in item 3 above) - ? 38,31,062.45/-

 

5.        Details of CSR spend during the financial year:

 

(a) Total amount to be spent for the financial year:  ?38,31,062.45/-

(b) Amount unspent, if any: ? 64,99,819.44/- (This amount includes previous years CSR unspent figures    too.)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(c) Manner in which the amount spent during the financial year is detailed below:

 

Sr.

No.

CSR project or activity identified

Sector in which the project is covered

Projects or programs

(1) Local area or other

(2) Specify the state and district where projects or programs was undertaken

Amount outlay (budget) project or programs wise

Amount spent on the projects or programs sub-heads

(1) Direct expenditure on projects or programs

(2) Overheads (Rs.)

Cumulative expenditure upto the reporting period (Rs.)

Amount spent: Direct or through implementing agency

1.

Provide medical services and Health Check up services to villagers

 

Healthcare

Village: Lakhigam, Dahej, Bharuch, Gujarat

---

Direct Expenditure:

3,21,667/-

4,18,399

Direct

Overhead:

96,732/-

2.

Open Small Village Library

Promoting Education

Village: Lakhigam, Dahej, Bharuch, Gujarat

----

Direct Expenditure:

54,373/-

57,235

Direct

Overhead 2,862/-

3.

POSCO Mitra Project run by Baroda Citizen Council  

Promoting Education

Vadodara

---

25,000/-

25,000

Through Implementing Agency-Baroda Citizen Council

 

TOTAL

 

 

 

5,00,634

5,00,634

 

 

 

6.        In case the Company has failed to spend the two per cent of the average net profit of the last three financial years or any part thereof, the company shall provide the reasons for not spending the amount in its Board Report:

 

The CSR Committee of the Company is on lookout for other relevant projects or programmes in vicinity of Companies factories/locations as permissible under Schedule VII of the Companies Act, 2013.

 

7.        A responsibility statement of the CSR Committee that the implementation and monitoring of CSR Policy,is in compliance with CSR objectives and Policy of the Company.

 

The CSR Committee confirms that the implementation and monitoring of the CSR Policy, is in compliance with CSR objectives and Policy of the Company.

 

 

FOR AND ON BEHALF OF BOARD OF DIRECTORS

                    TATVA CHINTAN PHARAM CHEM PRIVATE LIMITED

 

 

 

 

Date: September 21 , 2019

Place: Ankleshwar

 Mr. Ajay Patel

(Chairman of CSR Committee)

 

 Mr.Shekhar Somani

(Member)

 

 

ANNEXURE IV

 

 

FORM NO. MGT 9

           

EXTRACT OF ANNUAL RETURN AS ON FINANCIAL YEAR ENDED ON 31-03-2019

 

Pursuant to Section 92(3) of the Companies Act, 2013 and rule 12(1) of the Companies (Management and Administration) Rules, 2014.

 

I.  REGISTRATION AND OTHER DETAILS:

CIN

U24232GJ1996PTC029894

Registration Date

June 12, 1996

Name of the Company

Tatva Chintan Pharma Chem Private Limited

Category/Sub-category of the Company

Private Company

Limited by Shares

Company having Share Capital

Address of the Registered Office and contact details

Plot No 502/17,GIDC Estate, Ankleshwar GIDC,

Ankleshwar, Bharuch -393002

Gujarat, India.

 

Phone: 265-2437093  

Fax:265-2638533  

E-mail : chintan@tatvachintan.com

Whether listed company

No

 

 

 

II.PRINCIPAL BUSINESS ACTIVITIES OF THE COMPANY:

(All the business activities contributing 10 % or more of the total turnover of the company shall be stated)

 

Sr.

No.

Name and Description of main products/services

NIC Code of the Product/Service

% to total turnover of the company

1

Quaternary Compounds

20299

87.68

 

2

Others

21001

12.32

 

 

III.    PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES:

 

Sr.

No.

Name and address of the Company

CIN/GLN

Holding/Subsidiary/ Associate

% of shares held

Applicable Section

1

TatvaChintan USA Inc.,

950, Taylor Ave, Suite 230A, Grand Haven, MI 49417, USA

NA

Subsidiary

100 %

2(87)

2

Tatva Chintan Europe BV*

6005, Luzern
Switzerland

NA

Subsidiary

100 %

2(87)

*Tatva Chintan Europe BV - A wholly owned subsidiary with authorised share capital of Euro 120 was incorporated on March 01,2019 . The remittance towards subscription of share capital has not been made up to March, 31,2019.

 

 

Note: The Company has no holding company.

 

 

 

 

 


IV. SHARE HOLDING PATTERN (Equity Share Capital Break-up as percentage of Total Equity)

(i)                 Category-wise Share Holding

Sr.

No.

Category of Shareholders

No. of shares held at the beginning of the year
[As on 01.04.2018]

No. of Shares held at the end of the year
[As on 31.03.2019]

% change during the year

Equity Shares

% of Total Shares

Equity Shares

% of Total Shares

A.

PROMOTERS

 

 

 

 

 

(1)

INDIAN

 

 

 

 

 

a)

Individual/HUF

69,78,380

86.85%

69,78,380

86.85%

0.00%

b)

Central Government

-

-

-

-

-

c)

State Government(s)

-

-

-

-

-

d)

Bodies Corporate

-

-

-

-

-

e)

Banks/Financial Institution

-

-

-

-

-

f)

Any other

-

-

-

-

-

 

SUB-TOTAL ((A)(1)

 

 

 

 

 

(2)

FOREIGN

-

-

-

-

-

a)

NRIs - Individuals

-

-

-

-

-

b)

Other - Individuals

-

-

-

-

-

c)

Bodies Corporate

-

-

-

-

-

d)

Banks/Financial Institutions

-

-

-

-

-

e)

Any other

-

-

-

-

-

 

SUB-TOTAL (A)(2)

-

-

-

-

-

 

Total Shareholding of Promoter (A) = (A)(1) + (A)(2)

69,78,380

86.85%

69,78,380

86.85%

0.00%

B.

PUBLIC\OTHER THAN PROMOTERS

 

 

 

 

 

(1)

INSTITUTIONS

-

-

-

-

-

a)

Mutual Funds

-

-

-

-

-

b)

Banks/Financial Institutions

-

-

-

-

-

c)

Central Government

-

-

-

-

-

d)

State Government(s)

-

-

-

-

-

e)

Venture Capital Funds

-

-

-

-

-

f)

Insurance Companies

-

-

-

-

-

g)

Foreign Institutional Investors

-

-

-

-

-

h)

Foreign Venture Capital Funds

-

-

-

-

-

i)

Others (Sepcity)

-

-

-

-

-

 

SUB-TOTAL (B)(1)

-

-

-

-

-

(2)

NON-INSTITUTIONS

-

-

-

-

-

a)

Bodies Corporate -

-

-

-

-

-

(i)

Indian

-

-

-

-

-

(ii)

Overseas

-

-

-

-

-

b)

Individuals

 

 

 

 

 

(i)

Individual shareholders holding nominal share capital uptoRs. 1 Lakh

4,500

0.06%

4,500

0.06%

0.00%

(ii)

Individual shareholders holding nominal share capital in excess ofRs. 1 lakh

10,52,120

13.09%

10,52,120

13.09%

0.00%

c)

Others (specify)

-

-

-

-

-

 

SUB-TOTAL (B)(2)

10,56,620

13.15%

17,30,620

21.54%

0.00%

 

Total Public Shareholding (B) = (B)(1) + (B)(2)

10,56,620

13.15%

17,30,620

21.54%

0.00%

C

SHARES HELD BY CUSTODIAN FOR GDRS & ADRS

-

-

-

-

-

GRAND TOTAL (A+B+C)

80,35,000

100 %

80,35,000

100 %

0.00 %

 

 

 

 

 

(ii)               SHAREHOLDING OF PROMOTERS :

 

Sr.

No.

Shareholder's Name

Shareholding at the beginning of the year

 [As on 01.04.2018]

Shareholding at the end of the year

 [As on 31.03.2019]

% change in share

holding during the year

No. of Equity Shares

% of Total Shares of the Company

% of Shares encum-bered to total shares

No. of Equity Shares

% of Total Shares of the Company

% of Shares encum-bered to total shares

1

Chintan N. Shah

22,59,500

28.12 %

-

22,59,500

28.12 %

-

-

2

Ajay M. Patel

16,88,900

21.02 %

-

16,88,900

21.02 %

-

-

3

Shekhar R. Somani

23,55,980

29.32 %

-

23,55,980

29.32 %

-

-

4

Chintan Shah HUF

1,79,000

2.28%

-

1,79,000

2.28%

-

-

5

Ajay Patel HUF

4,95,000

6.16%

-

4,95,000

6.16%

-

-

 

 

(iii) CHANGE IN PROMOTER'S SHAREHOLDING (Please specify, if there is no change)

Sr.

No.

Particulars

Shareholding at the beginning of the year

[As on 01.04.2018]

Transaction
during the year

Cumulative Shareholding during the year

[01.04.2018 to 31.03.2019]

No. of Equity Shares

% of total shares of the Company

Date

Increase/
Decrease

Reason

No. of Equity Shares

% of total shares of the Company

1

At the beginning of the year

69,78,380

86.85%

-

-

-

69,78,380

86.85%

2.

At the end of the year

69,78,380

86.85%

-

-

-

69,78,380

86.85%

 

 

Note: There is no change in the total shareholding of promoters between 01.04.2018 to 31.03.2019.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(iv) SHAREHOLDING PATTERN OF TOP TEN SHAREHOLDERS

(Other than Directors, Promoters and Holders of GDRS and ADRS)

 

There are Total Nine shareholders who falls under this category. Except below others are directors and promoter's shareholders.

Sr.

No.

Particulars

Shareholding at the beginning of the year (01.04.2018)

Transaction
during the year

Cumulative Shareholding at the end of the year
(31.03.2019)

No. of Equity Shares

% of total shares of the Company

Date

Increase/
Decrease

Reason

No. of Equity Shares

% of total shares of the Company

1

Priti A. Patel

4,94,400

6.15%

-

-

-

4,94,400

6.15%

2

Darshanaben N. Shah

1,47,400

1.83%

-

-

-

1,47,400

1.83%

3

Kajal  S. Somani

1,27,860

1.59%

-

-

-

1,27,860

1.59%

4

Rasiklal N. Somani

1,08,560

1.35%

-

-

-

1,08,560

1.35%

5

Shital C. Shah

92,400

1.15%

-

-

-

92,400

1.15%

6

Ranjanben R. Somani

57,300

0.71%

-

-

-

57,300

0.71%

7

Samir R. Somani

24,200

0.30%

-

-

-

24,200

0.30%

8

Sheetal R. Somani

4,400

0.05%

-

-

-

4,400

0.05%

9

Pravin Chandra &Co.

100

0.001%

-

-

-

100

0.001%

 

(v)SHAREHOLDING OF DIRECTORS AND KEY MANAGERIAL PERSONNEL:

 

Sr.

No.

Name of Directors

Shareholding at the beginning of the year

[As on 01.04.2018]

Transaction
during the year

Cumulative Shareholding during the year

[01.04.2018 to 31.03.2019]

No. of Equity Shares

% of total shares of the Company

Date

Increase/
Decrease

Reason

No. of Equity Shares

% of total shares of the Company

1

Chintan Shah

22,59,500

28.12%

-

-

-

22,59,500

28.12%

2.

Shekhar Somani

23,55,980

29.32%

-

-

-

23,55,980

29.32%

3.

Ajay Patel

16,88,900

21.02%

-

-

-

16,88,900

21.02%

 

Note: Key Managerial Personnel do not hold any shares of the Company during the year under review.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

V.INDEBTEDNESS :

 

Particulars

Secured Loans excluding deposits

Unsecured Loans

Deposits

Total

Indebtedness

Indebtedness at the beginning of the financial year (01/04/2018)

 

 

 

 

i)   Principal Amount

5,614.56

0.00

0.00

5,614.56

ii)  Interest due but not paid

0.00

0.00

0.00

0.00

iii) Interest accrued but not due

0.00

0.00

0.00

0.00

Total (i+ ii + iii)

5,614.56

0.00

0.00

5,614.56

Change in Indebtedness during the financial year

 

 

 

 

Addition

4230.51

0.00

0.00

4230.51

Reduction

2130.30

0.00

0.00

2130.30

Net Change

2100.21

0.00

0.00

2100.21

Indebtedness at the end of the financial year (31/03/2019)

 

 

 

 

i)   Principal Amount

7,714.77

0.00

0.00

7,714.77

ii)  Interest due but not paid

0.00

0.00

0.00

0.00

iii) Interest accrued but not due

0.00

0.00

0.00

0.00

Total (i+ ii + iii)

7,714.77

0.00

0.00

7,714.77

Indebtedness of the Company including interest outstanding/accrued but not due for payment

(? in Lacs)

                                                                                  

 

VI. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL

A.Remuneration to Managing Director, Whole-time Directors and/or Manager:(?. In Crores)

Sr.

No.

Particulars of Remuneration

Name of MD/WTD/Manager

Total Amount

Chintan N. Shah

Ajay M. Patel

Shekhar R. Somani

1

Gross Salary

 

 

 

 

 

(a)  Salary as per provisions contained in

      Section 17(1) of the Income-tax Act,

     1961

1.44

1.44

1.44

4.32

 

(b)  Value of perquisites u/s. 17(2) of the

      Income-tax Act, 1961

0.00

0.00

0.00

0.00

 

(c)  Profits in lieu of salary under section

     17(3) of the Income-tax Act, 1961

0.00

0.00

0.00

0.00

2

Stock Option

0.00

0.00

0.00

0.00

3

Sweat Equity

0.00

0.00

0.00

0.00

4

Commission

-   As % of Profit

-   others, specify

0.00

0.00

0.00

0.00

5

Others, Please Specify

0.00

0.00

0.00

0.00

6

Total (A)

1.44

1.44

1.44

4.32

7.

Ceiling as per the Act

Not Applicable

Not Applicable

Not Applicable

Not

Applicable

 

B.REMUNERATION TO OTHER DIRECTORS:

                                                                                                                                    (?. In Lacs)

Sr.

No.

Particulars of Remuneration

Name of Directors

Total Amount

NAME

NAME

NAME

 

1

Independent Directors

NA

NA

NA

NA

 

-  Fees for attending board committee

   Meetings

-  Commission

-  Others, please specify

NA

NA

NA

NA

 

TOTAL (1)

NA

NA

NA

NA

2

Other Non-Executive Directors

NA

NA

NA

NA

 

-  Fees for attending board committee

   Meetings

-  Commission

-  Others, please specify

NA

NA

NA

NA

 

TOTAL (2)

NA

NA

NA

NA

 

TOTAL (B) = (1) + (2)

NA

NA

NA

NA

 

Total Managerial Remuneration (A) + (B)

NA

NA

NA

NA

 

Overall Ceiling as per the Act

NA

NA

NA

NA

 

C.REMUNERATION TO KEY MANAGERIAL PERSONNEL OTHER THAN MD/MANAGER/WTD

(?. In Lacs)

Sr.

No.

Particulars of Remuneration

Mr. Sudip Sanat Ray

Chief Financial Officer*

Ms. Hiral Gediya

Company Secretary

 

Total

1

Gross Salary

 

 

 

 

(a)  Salary as per provisions contained in

      Section 17(1) of the Income-tax Act,

     1961

4.15

2.00

6.15

 

(b)  Value of perquisites u/s. 17(2) of the

      Income-tax Act, 1961

0.00

0.00

0.00

 

(c)  Profits in lieu of salary under section

     17(3) of the Income-tax Act, 1961

0.00

0.00

0.00

2

Stock Option

0.00

0.00

0.00

3

Sweat Equity

0.00

0.00

0.00

4

Commission

 As % of Profit

 others, specify

0.00

0.00

0.00

5

Others, Please Specify

0.00

0.00

0.00

 

TOTAL

4.15

2.00

6.15

 

Note:

*Mr. Sudip Sanat Ray has been appointed as Chief Financial Officer of the Company on 05/10/2018 and his employment ceased as a Chief Financial Officer of the Company w.e.f.close of working hours of 25/02/2019.

 

 

 

 

 

VII. PENALTIES/PUNISHMENT/COMPOUNDING OF OFFENCES:

 

Sr.

No.

Type

Section of the Companies Act

Brief Description

Details of Penalty/ Punishment/ Compounding fees imposed

Authority

(RD/NCLT/ COURT)

Appeal made, if any (give Details)

A.

COMPANY

 

 

 

 

 

Penalty

 

 

 

 

 

 

Punishment

 

 

 

 

 

 

Compounding

 

 

 

 

 

B

DIRECTORS

 

 

 

 

 

 

Penalty

 

 

NONE

 

 

 

Punishment

 

 

 

 

 

 

Compounding

 

 

 

 

 

C

OTHER OFFICERS IN DEFAULT

 

 

 

 

 

 

Penalty

 

 

 

 

 

 

Punishment

 

 

 

 

 

 

Compounding

 

 

 

 

 

 

                                                                                               

 

FOR AND ON BEHALF OF BOARD OF DIRECTORS

                           TATVA CHINTAN PHARAM CHEM PRIVATE LIMITED

 

 

 

 

Date: September 21, 2019

Place: Ankleshwar

  Mr. Ajay Patel

(Director)

(DIN: 00183745)

 

Mr. Shekhar Somani

(Director)

(DIN: 00183665)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

         

 


 

 

Chandani Ma'm